Literature DB >> 14169837

STUDY OF LYSERGIC ACID DIETHYLAMIDE AS AN ANALGESIC AGENT.

E C KAST, V J COLLINS.   

Abstract

Entities:  

Keywords:  ANALGESICS AND ANTIPYRETICS; CLINICAL RESEARCH; DIHYDROMORPHINONE; LYSERGIC ACID DIETHYLAMIDE; MEPERIDINE; PAIN; PHARMACOLOGY; PHYSIOLOGY; PSYCHOLOGY

Mesh：

Substances：

Year:  1964        PMID： 14169837

Source DB:  PubMed          Journal:  Anesth Analg        ISSN： 0003-2999            Impact factor:   5.108


× No keyword cloud information.
  27 in total

Review 1.  Human hallucinogen research: guidelines for safety.

Authors:  Mw Johnson; Wa Richards; Rr Griffiths
Journal:  J Psychopharmacol       Date:  2008-07-01       Impact factor: 4.153

Review 2.  Clinical applications of hallucinogens: A review.

Authors:  Albert Garcia-Romeu; Brennan Kersgaard; Peter H Addy
Journal:  Exp Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.157

Review 3.  Lysergic acid diethylamide: a drug of 'use'?

Authors:  Saibal Das; Preeti Barnwal; Anand Ramasamy; Sumalya Sen; Somnath Mondal
Journal:  Ther Adv Psychopharmacol       Date:  2016-03-23

4.  The abdominal constriction response and its suppression by analgesic drugs in the mouse.

Authors:  H O Collier; L C Dinneen; C A Johnson; C Schneider
Journal:  Br J Pharmacol Chemother       Date:  1968-02

5.  Attenuation of anticipation: a therapeutic use of lysergic acid diethylamide.

Authors:  E Kast
Journal:  Psychiatr Q       Date:  1967-10

6.  Stimulus intensity modulation and psychological dis-ease.

Authors:  J Silverman
Journal:  Psychopharmacologia       Date:  1972

Review 7.  Embedding existential psychology within psychedelic science: reduced death anxiety as a mediator of the therapeutic effects of psychedelics.

Authors:  Sam G Moreton; Luke Szalla; Rachel E Menzies; Andrew F Arena
Journal:  Psychopharmacology (Berl)       Date:  2019-11-29       Impact factor: 4.530

8.  Serotonergic and dopaminergic distinctions in the behavioral pharmacology of (±)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and lysergic acid diethylamide (LSD).

Authors:  Emmanuelle A D Schindler; Kuldip D Dave; Elaine M Smolock; Vincent J Aloyo; John A Harvey
Journal:  Pharmacol Biochem Behav       Date:  2011-12-14       Impact factor: 3.533

Review 9.  Potential Therapeutic Effects of Psilocybin.

Authors:  Matthew W Johnson; Roland R Griffiths
Journal:  Neurotherapeutics       Date:  2017-07       Impact factor: 7.620

10.  Interaction between narcotic antagonist (naloxone) and lysergic acid diethylamide (LSD) in the rat.

Authors:  A P Fertziger; R Fischer
Journal:  Psychopharmacology (Berl)       Date:  1977-11-15       Impact factor: 4.530
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.